Authors
Latest:
Andrew Satlin, MD: Lumateperone for Agitation in Patients with Dementia, Alzheimer DiseaseData from an interim analysis of the lumateperone large phase III clinical trial for agitation in subjects with dementia is expected by the end of 2018.
Latest:
Kelvin Tsoi, PhD: Combination Therapy, Monotherapy in Alzheimer DiseaseAfter identifying and reviewing 76 randomized trials, combination therapy with memantine and AChEIs is confirmed to have no additional benefits over monotherapy.
Latest:
Exploring the Burden of Cerebrovascular Disease in VirginiaLocated in the “Stroke Belt” of the US, Virginia presents a unique perspective on the interplay of social, ethnic, and cultural implications on population health.
Latest:
David Wolk, MD: Utilizing MRI in Alzheimer DiseaseThe co-director of the University of Pennsylvania Memory Center will share additional insights on Alzheimer disease at the upcoming International Congress on the Future of Neurology, taking place September 27-28, 2019 in New York City.
Latest:
The Future Outlook for Alzheimer’s DiseaseSharon Cohen, MD, and Marwan Sabbagh, MD, share their final thoughts on Alzheimer's disease and offer advice on strategies to reduce the risk of developing AD and slow the progression of the disease for those already affected.
Latest:
Jenny van der Steen, PhD: Utilizing Palliative Care in DementiaThe associate professor at Leiden University Medical Center detailed how palliative care can be used more effectively in patients with dementia.
Latest:
Clinically Relevant Challenges and Roadblocks of Gene Therapies for Muscular Dystrophies: John Brandsema, MDThe pediatric neurologist at Children’s Hospital of Philadelphia gave perspective on some of the main issues the clinical community is figuring out with gene therapies and their integration to clinical practice. [WATCH TIME: 3 minutes]
Latest:
Refining Our Strategy in Alzheimer Disease: Amyloid, Tau, and BeyondReisa Sperling, MD sat down with NeurologyLive to discuss why she thinks investigational drugs for Alzheimer disease are failing, and what she feels are the most promising treatment avenues.
Latest:
Howard Weiner, MD: Entering a New Era in MSThe director of the Partners Multiple Sclerosis Center at Brigham and Women's Hospital spoke about the future of multiple sclerosis.
Latest:
Complexities With SMN2 Copies in Spinal Muscular Atrophy: Basil Darras, MDThe associate neurologist-in-chief at Boston Children’s Hospital discussed the 4-copy conundrum and whether treatment decisions differ based on SMN2 copies for patients with spinal muscular atrophy. [WATCH TIME: 2 minutes]
Latest:
The Role of Aging in Multiple Sclerosis CareExperts discussed how aging impacts multiple sclerosis management, treatment decisions, and overall patient health. [WATCH TIME: 5 minutes]
Latest:
Kate Davis, MD, MSTR: Increasing Treatment Options for Epilepsy PatientsThe epileptologist at the University of Pennsylvania spoke about the multiple options for patients with epilepsy and the need for a better understanding of choosing from the options.
Latest:
FDA Approves Riptide Aspiration System for Acute Ischemic StrokeThe FDA has approved the Riptide Aspiration System for thrombus retrieval via the Arc Catheter for revascularization in patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease.
Latest:
Marking a New Era in Patient Care With Advancements in Disease-Modifying Alzheimer Treatments: Alireza Atri, MD, PhDThe director of the Banner Sun Health Research Institute talked about how the newly approved Alzheimer treatments have shown promise in slowing clinical decline, signaling a foundational shift toward disease-modifying therapies that target core biological processes. [WATCH TIME: 5 minutes]
Latest:
Pediatric Sleep Disorders: Assessment and TreatmentThe long-term consequences of untreated—and prevalent—sleep disorders in children and adolescents point to a need for a focus on this field of care.
Latest:
David Langer, MD: Answering the Call for COVID-19The chair of neurosurgery at Lenox Hill Hospital in Manhattan recently joined the ranks of health care providers who are caring for COVID-19 patients at the temporary hospital set up in the Javits Center.
Latest:
Tessa Blanken, MSc: Identification of Robust, Clinically Relevant Insomnia SubtypesThe identification of the subtypes allows future studies to target homogeneous subtype samples, resolve inconsistencies, personalize treatment and utilize preventive interventions.
Latest:
Marc Nuwer Explores the 2019 CPT Codes for EpilepsyThe professor and vice chair of the neurology department at UCLA discussed the new VNS, RNS and DBS CPT codes for 2019.
Latest:
Joshua Cohen, MD: Fremanezumab's Impact on Quality of Life and ComorbiditiesThe Global Medical Lead for Migraine and Headache at Teva Pharmaceuticals provided insight into how fremanezumab has helped to improve these facets of the condition.
Latest:
Eight Ways to Evaluate a Telehealth VendorA look at the questions you should be asking during the decision-making process of picking a telehealth vendor.
Latest:
Zachary Grinspan, MD, MS: Collaborating Across Specialties to Improve OutcomesThe director of the Pediatric Epilepsy Program and an MD candidate at Weill Cornell Medicine detail the steps needed to take to improve outcomes in status epilepticus.
Latest:
Sharon Chiang, MD, PhD: Recording Seizures With Detection TechnologyThe neurology resident at the University of California San Francisco discussed how new wearable technology and electronic diaries have helped improve the understanding of seizure rhythmicity, and ultimately, epilepsy care.
Latest:
Screening for Alzheimer Disease: Facilitating an Early Diagnosis for Prompt InterventionIn this episode of MEDcast, expert geriatric psychiatrists explore the urgent need for effective diagnostic methods that can detect Alzheimer’s disease at an early stage. We will discuss blood-based biomarkers and other advancements that can help screen Alzheimer’s disease non-invasively and early in the disease course.
